Related Experiment Video
Updated: Mar 28, 2026
10:07
Using Learning Outcome Measures to assess Doctoral Nursing Education
Published on: June 21, 2010
19.6K
Making a Curricular Commitment to Continuing Professional Development in Doctor of Pharmacy Programs.
Kristin K Janke1, Toyin Tofade2
1University of Minnesota College of Pharmacy, Minneapolis, Minnesota.
American Journal of Pharmaceutical Education
|December 23, 2015
Summary
Continuing professional development (CPD) fosters self-directed learning in pharmacy education. This statement defines CPD skills and recommends curriculum integration to prepare "CPD ready" practitioners.
Area of Science:
- Pharmacy Education
- Professional Development
Background:
- Accreditation Council for Pharmacy Education (ACPE) Standards 2016 mandate environments promoting self-directed lifelong learning.
- Continuing Professional Development (CPD) models support lifelong learning and attainment of Center for the Advancement of Pharmaceutical Education (CAPE) 2013 Outcomes.
- CPD aids in experiential learning individualization and student response to feedback.
Purpose of the Study:
- To define the skill sets essential for Continuing Professional Development (CPD).
- To provide recommendations for integrating CPD into pharmacy curricula.
- To assist pharmacy schools in developing "CPD ready" practitioners.
Main Methods:
- Analysis of existing pharmacy curricula regarding CPD skill development.
- Identification of isolated or non-learning-focused application of CPD skills like reflection and documentation.
Main Results:
- Pharmacy curricula often address CPD skills (reflection, documentation) but may not integrate them effectively for lifelong learning.
- Current approaches may develop these skills in isolation or for purposes other than learning.
Conclusions:
- Effective integration of CPD into pharmacy curricula is crucial for developing self-directed lifelong learners.
- Defining and recommending specific CPD skill sets can enhance practitioner readiness.
- Pharmacy schools should proactively advance CPD to meet accreditation standards and educational outcomes.
Related Concept Videos
01:26Drug Administration and Therapy Phases: Overview
1.7K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.7K
01:28Dosage Regimens: Designs and Approaches
460
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
460
01:26Oral Drug Delivery Systems: Continuous-Release Systems
208
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
208
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
71
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
71
01:26Pharmaceutical Poisoning: Potential Scenarios
77
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
77
01:28Biopharmaceutics and Pharmacokinetics: Overview
5.0K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
5.0K